BioMap profiling can provide in-depth characterization of drug function, including defining mechanism of action and secondary activities, and can provide insights into potential clinical applications.
BioMap systems are designed to replicate the intricate cell and pathway interactions present in human disease biology. Depending on their mechanism of action, compounds induce specific patterns of changes in these systems (BioMap profiles) that can be compared to a large number of reference profiles in BioSeek’s database.
“We are excited to be working closely with the innovative scientific teams in GSK as we continue to demonstrate the utility of BioMap Systems to drive drug discovery,” commented Peter Staple, CEO of BioSeek. “This collaboration will enable us to make use of the full range of applications of our technology.”